RETHINK ADHD SYMPTOM CONTROL
associated with 47 other trademarks
Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous s...

Words that describe this trademark:

central nervous system  peripheral nervous system  nervous system peripheral  treatment prevention  system peripheral  pharmaceutical preparations  prevention  therapeutic  humans  preparations 

Serial Number:

90287870

Mark:

RETHINK ADHD SYMPTOM CONTROL

Status:

Registered

Status Date:

03-08-2022

Filing Date:

Registration Number:

6668162

Registration Date:

03-08-2022

Goods and Services:

Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders

Mark Description:

The mark consists of a stylized version of the literal element "RETHINK ADHD SYMPTOM CONTROL" in a single, horizontal line.

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

05-18-2021

Mark Drawing Status:

Words, Letters, and/or Numbers in Stylized From

Abandon Date:

N/A

Business Name:

SAUL EWING ARNSTEIN & LEHR

Correspondent Name:

Recent Trademark filings by this company